Proteomics for precision medicine: Next-generation testing to indicate future cardiovascular risk and improve outcomes
Proteomics for precision medicine: Next-generation testing to
indicate future cardiovascular risk and improve outcomes
Proteomic testing can reveal multiple answers to clinical questions that allow providers to better predict, monitor, and prevent the escalation of cardiovascular disease (CVD). This allows providers to move the needle away from the practice of late-stage treatment and toward treating at-risk patients sooner and before a major cardiovascular (CV) event.
Topics covered include:
- The capabilities of proteomics
- How comprehensive protein detection technology can accurately predict major cardiovascular events
- How proteomic testing can ultimately improve outcomes
Nelson Trujillo, MD
Cardiologist
Boulder Heart at Anderson Medical Center
Rosalyn Gill, PhD
Vice President, Medical Affairs
SomaLogic, Inc.
Todd Johnson
Executive Vice President, Diagnostics
Business Unit
SomaLogic, Inc.
Proteomics for precision medicine: Next-generation testing to indicate future cardiovascular risk and improve outcomes
A presentation by Nelson Trujillo, MD, Rosalyn Gill, PhD, and Todd Johnson
More webinars
WebinarAccelerating precision medicine of cancer with SomaScan® proteomics
Proteomics has emerged as the next frontier in precision medicine, and several innovative proteomics platforms have been developed to drive biomarker discovery. We [at Beth Israel Deaconess Medical Center] are using the currently most comprehensive proteomics technology -- the SomaScan Platform, which measures 7,000 proteins -- to discover and independently validate diagnostic, predictive, and prognostic biomarkers for various cancers.
WebinarImproving clinical development productivity with high-plex proteomics
While the vast majority of approved pharmaceuticals target proteins, knowledge of the full complement of proteins that are acted on by drugs, or are potentially druggable, remains incomplete. Assessment of the human proteome is thus increasingly recognized as a priority for successful and cost-effective drug development and clinical research.
WebinarMillions for Proteomics Research in the Peer Reviewed Medical Research Program
How SomaLogic Technologies can give your research programs an edge